LIVN News and Press, LivaNova PLC From 06/15/21

Company to launch OSPREY investigational device exemption clinical study in the U.S. LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to proceed w...

NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of ...

Additional local business closings to occur later this year LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has successfully completed the initial closing of the divestiture of its heart valve (HV) business to Gy...

The leading player in the market for blood plasma collection equipment. The plasma market is a duopoly with Fresenius in a distant number two position. Recent price weakness represents a significant opportunity to own a good quality leader at a very good price. The market has over...

Haemonetics shares have been punished since April on the back of CSL Plasma's decision not to renew the use of PCS2 from June 2022. Shares immediately saw a gap-fill to the downside and have shown downward pressures since, however, fundamentally little has changed. Theoretically ~...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25 at 8 a.m. Eastern Time. The discussion will be available ...

LivaNova Plc continues its excellent turnaround story that commenced in October 2020, since 2.2% owner Prime Capital LLP's scathing letter. Shareholders have enjoyed +65% upside from this point until today, and the technical picture corroborates more upside on the charts. We are l...

LivaNova PLC (LIVN) Q1 2021 Earnings Conference Call April 28, 2021 7:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Interim Chief Financial Officer Melissa Farina - Vice President of In...

The following slide deck was published by LivaNova PLC in conjunction with their 2021 Q1 earnings call. For further details see: LivaNova PLC 2021 Q1 - Results - Earnings Call Presentation

After a post-earnings rally yesterday, one healthcare equipment company reached up and touched $90/share, for just a minute - and "stocks that go to $90 tend to go to $100," or so the aphorism goes, Baird notes. But $100 is its new price target for LivaNova (LIVN), which closed Wednesday up 4...